1. Home
  2. RPHM vs KULR Comparison

RPHM vs KULR Comparison

Compare RPHM & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPHM
  • KULR
  • Stock Information
  • Founded
  • RPHM 2014
  • KULR 2013
  • Country
  • RPHM United States
  • KULR United States
  • Employees
  • RPHM N/A
  • KULR N/A
  • Industry
  • RPHM Biotechnology: Pharmaceutical Preparations
  • KULR Electrical Products
  • Sector
  • RPHM Health Care
  • KULR Technology
  • Exchange
  • RPHM Nasdaq
  • KULR Nasdaq
  • Market Cap
  • RPHM 47.5M
  • KULR 55.3M
  • IPO Year
  • RPHM 2021
  • KULR N/A
  • Fundamental
  • Price
  • RPHM $1.82
  • KULR $0.30
  • Analyst Decision
  • RPHM Hold
  • KULR Buy
  • Analyst Count
  • RPHM 6
  • KULR 1
  • Target Price
  • RPHM $2.26
  • KULR $1.00
  • AVG Volume (30 Days)
  • RPHM 345.4K
  • KULR 2.0M
  • Earning Date
  • RPHM 11-11-2024
  • KULR 11-12-2024
  • Dividend Yield
  • RPHM N/A
  • KULR N/A
  • EPS Growth
  • RPHM N/A
  • KULR N/A
  • EPS
  • RPHM N/A
  • KULR N/A
  • Revenue
  • RPHM N/A
  • KULR $9,555,967.00
  • Revenue This Year
  • RPHM N/A
  • KULR N/A
  • Revenue Next Year
  • RPHM N/A
  • KULR $99.14
  • P/E Ratio
  • RPHM N/A
  • KULR N/A
  • Revenue Growth
  • RPHM N/A
  • KULR 24.72
  • 52 Week Low
  • RPHM $0.98
  • KULR $0.10
  • 52 Week High
  • RPHM $9.21
  • KULR $0.90
  • Technical
  • Relative Strength Index (RSI)
  • RPHM 69.89
  • KULR 58.24
  • Support Level
  • RPHM $1.61
  • KULR $0.27
  • Resistance Level
  • RPHM $1.75
  • KULR $0.31
  • Average True Range (ATR)
  • RPHM 0.13
  • KULR 0.02
  • MACD
  • RPHM 0.04
  • KULR 0.00
  • Stochastic Oscillator
  • RPHM 87.30
  • KULR 80.50

About RPHM Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.

Share on Social Networks: